Keywords: Flow cytometry; Intracellular protein; Monoclonal antibody; Primary immunodeficiency disease; Surface protein; ADA; adenosine deaminase; ALPS; autoimmune lymphoproliferative syndrome; APECED; autoimmune polyendocrinopathy-candidiasis-ectodermal dystrop
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Wiskott-Aldrich syndrome; platelet deficiency; CD40 ligand; autoantibodies; autoimmunity; Anti-PLT autoAb; Anti-platelet autoantibody; FACS; Fluorescence-activated cell sorting; HD; Healthy donor; MFI; Mean fluorescence intensity; MK; Megakaryocyte; PPP;
R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome
Keywords: Primary immunodeficiency; Wiskott-Aldrich syndrome; X-linked thrombocytopenia; TH1/TH2 differentiation; R-loops; DNA damage; genomic instability; ChIP; Chromatin immunoprecipitation; DDR; DNA damage response; DRB; 5,6-Dichlorobenzimidazole-1-β-D-ribofura
Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
Keywords: WAS; Wiskott-Aldrich syndrome; XLT; X-linked thrombocytopenia; IL-2; interleukin 2; Treg; T regulatory cell; Low dose IL-2; Wiskott-Aldrich syndrome; X-linked thrombocytopenia;
X-linked thrombocytopenia in a female with a complex familial pattern of X-chromosome inactivation
Keywords: Wiskott–Aldrich syndrome; X-linked thrombocytopenia; X-chromosome inactivation; WAS gene; Primary immunodeficiency
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding
Keywords: Wiskott-Aldrich syndrome; WASP; WIP; T cells; actin cytoskeleton; aa; Amino acid; EGFP; Enhanced green fluorescent protein; EBV-B; EBV-transformed B; Ena/VASP; Enabled/vasodilator-stimulated phosphoprotein; EVH1; Ena-VASP homology domain 1; MFI; Mean fluo
Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: Advances in Biology and Future Directions for Treatment
Keywords: Wiskott-Aldrich syndrome; Chimerism; X-linked thrombocytopenia; Hematopoietic cell transplantation; Immunodeficiency;
Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment
Keywords: Wiskott-Aldrich syndrome; Wiskott-Aldrich syndrome protein; X-linked thrombocytopenia; Hematopoietic stem cell transplantation; Reduced-intensity conditioning regimen
Detection of 28 novel mutations in the Wiskott–Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR
Keywords: Novel mutations; WAS gene; Wiskott–Aldrich syndrome; X-linked thrombocytopenia; Multiplex PCR
The Wiskott-Aldrich syndrome
Keywords: Wiskott-Aldrich syndrome; X-linked thrombocytopenia; X-linked neutropenia; function of WASP; immune defects; scoring system; mutation analysis; mutational hotspots; genotype-phenotype correlation; hematopoietic stem cell transplantation; gene therapyArp2/